tiprankstipranks

Analyst Profile

Followed by 263 followers
.
Jason Kolbert

Jason Kolbert

Dawson James
Wall Street Analyst
#7,181 out of 7,979 Wall Street Analysts
#20,201 out of 22,345 experts

Success Rate

34%
131 out of 385 transactions made a profit

Average Return

-3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Jason Kolbert's trades since 2009 and holding each position for 1 Year would result in 34.03% of your transactions generating a profit, with an average return of -3.7% per rating.

Stock Rating Distribution

2KRatings
87.02% Buy
12.36% Hold
0.62% Sell
Distribution of Jason Kolbert's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Anavex Life Sciences
(AVXL)
Rating:Buy
Date:Jun 16, 2020 - Jun 16, 2021
Return:+407.40%
The most profitable rating made by Jason Kolbert

Jason Kolbert's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ANDS
Anadys Pharm
Aug 11, 2009
Buy
Upgraded
1Ratings
0.00%
DNDNQ
Dendreon Corp
May 08, 2014
Hold
Downgraded
8Ratings
0.00%
FOMX
Foamix Pharma
Dec 16, 2014
Buy
Reiterated
2Ratings
0.00%
OCAT
Ocata Therapeutics
Dec 19, 2014
Hold
Reiterated
4Ratings
0.00%
ImmunoCellular Therapeutics
Mar 10, 2015
Buy
Reiterated
$3.00
(328.57% Upside)
7Ratings
0.00%
Synthetic Biologics
Mar 16, 2015
Hold
Downgraded
$3.00
(185.71% Upside)
8Ratings
0.00%
Palisade Bio
Mar 18, 2015
Sell
Reiterated
$0.25
(120.26% Upside)
2Ratings
0.00%
Vericel
Mar 24, 2015
Hold
Reiterated
3Ratings
0.00%
Vertex Pharmaceuticals
Mar 24, 2015
Hold
Reiterated
$121.00
(-59.77% Downside)
10Ratings
0.00%
Arbutus Biopharma
Jun 15, 2015
Hold
Downgraded
$14.00
(614.29% Upside)
18Ratings
0.00%
List of latest recommendations made by Jason Kolbert. Click to expand and see Jason Kolbert's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >